Hostname: page-component-848d4c4894-x24gv Total loading time: 0 Render date: 2024-06-07T16:14:13.084Z Has data issue: false hasContentIssue false

Antibodies in horses, mules and donkeys following monovalent vaccination against African horse sickness

Published online by Cambridge University Press:  15 May 2009

C. Hamblin
Affiliation:
AFRC Institute for Animal Health, Pirbright Laboratory, Pirbright, Woking, Surrey, GU24 0NF
P. S. Mellor
Affiliation:
AFRC Institute for Animal Health, Pirbright Laboratory, Pirbright, Woking, Surrey, GU24 0NF
S. D. Graham
Affiliation:
AFRC Institute for Animal Health, Pirbright Laboratory, Pirbright, Woking, Surrey, GU24 0NF
H. Hooghuis
Affiliation:
Laboratorio de Sanidad Y Produccion Animal, Ctra. Madrid-Irun Desv. Algete, Km 5400, 28110 Madrid, Spain
R. C. Montejano
Affiliation:
Laboratorio de Sanidad Y Produccion Animal, Ctra. Madrid-Irun Desv. Algete, Km 5400, 28110 Madrid, Spain
M. A. Cubillo
Affiliation:
Laboratorio de Sanidad Y Produccion Animal, Ctra. Madrid-Irun Desv. Algete, Km 5400, 28110 Madrid, Spain
J. Boned
Affiliation:
Junta de Andalucia, Laboratorio de Sanidad Y Produccion Animal, Apartado Correos 259, 14080 Codoba, Spain
Rights & Permissions [Opens in a new window]

Summary

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

A total of 256 sera collected from three species of domesticated equidae in four different Spanish provinces were examined 1–4 months after the administration of attenuated monovalent African horse sickness virus (AHSV) serotype 4 vaccine. Approximately 10% of the sera were negative by ELISA, virus neutralization, agar gel immuno-diffusion and complement fixation tests. Similar negative reactions were recorded with sera from two ponies after experimental primary vaccination. The rapid rise in antibodies in sera from these two ponies, after a second dose of vaccine, suggested they would probably have been immune to challenge. It is therefore suggested that the apparent absence of antibodies against AHSV in some animals after primary vaccination may not necessarily indicate a total lack of protection.

Type
Special Article
Copyright
Copyright © Cambridge University Press 1991

References

REFERENCES

1.Hamblin, C, Graham, SD, Anderson, EC, Crowther, JC. A competitive ELISA for the detection of group-specific antibodies to African horse sickness virus. Epidemiol Infect 1990; 104: 303–12.CrossRefGoogle ScholarPubMed
2.Eisa, M, McGrane, J, Taylor, WP, Ballouh, LA. Survey of precipitating antibodies to bluetongue virus in domestic animals in Sudan. Anim Health Prod Afr 1983; 31: 95–9.Google Scholar
3.Bernard, G. Adaptation de la microtechnique de fixation du complement au diagnostic de la peste equine. Rev Elev Med vet Pays trop 1975; 28: 451–7.CrossRefGoogle Scholar
4.Herniman, KAJ, Gumm, ID, Owen, L, Taylor, WP, Sellers, RF. Distribution of bluetongue virus and antibodies in some countries of the eastern hemisphere. Bull Off Int Epiz 1980; 92: 581–6.Google Scholar
5.Kärber, G. Beitrag zur kollectiven Behandlung pharmakologischer Reihenversuche. Arch Exp path Pharmak 1931; 162: 480–3.CrossRefGoogle Scholar
6.Ozawa, Y, Salama, SA, Dardiri, AH. Methods for recovering AHS in horse blood. In: Proceedings of the third international conference on equine infectious diseases. Paris: Karger, 1972: 5868.Google Scholar
7.Williams, R. A single dilution Enzyme-linked immunosorbent assay for the quantificative detection of antibodies to African horse sickness virus. Onderstepoort J Vet Res 1987; 54: 6770.Google Scholar